NCT05169892 Aquablation in Benign Prostatic Hyperplasia in Canada
| NCT ID | NCT05169892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Can-Am HIFU Inc. |
| Condition | Urologic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2019-10-09 |
| Primary Completion | 2023-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2019-10-09 with a primary completion date of 2023-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.
Eligibility Criteria
Inclusion Criteria: * Primary diagnosis of Benign Prostate Hypertrophy (BPH) * Male subjects of ≥ 18 years of age * Candidate for Aquablation therapy as per clinical decision of Investigator * Willing and able to accurately complete questionnaires * Willing and able to provide signed and dated informed consent Exclusion Criteria: * Characteristics indicating a poor compliance with study protocol requirements. * Disease or other health condition that is not suitable for this study. * Unable or unwilling to provide signed informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05169892 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Urologic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05169892 currently recruiting?
Yes, NCT05169892 is actively recruiting participants. Contact the research team at dean.elterman@uhn.ca for enrollment information.
Where is the NCT05169892 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT05169892 clinical trial?
NCT05169892 is sponsored by Can-Am HIFU Inc.. The trial plans to enroll 25 participants.